ReviewFrontiers in pharmacology2026

Targeting monoamine oxidases for the treatment of betel quid dependence: a potential pharmacological and neurobiological approach.

Sorbomita Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.